Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fulcrum Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FULC
Nasdaq
8731
https://www.fulcrumtx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fulcrum Therapeutics Inc
Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
- Mar 28th, 2024 8:05 pm
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 22nd, 2024 8:30 pm
Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
- Mar 18th, 2024 11:00 am
CEO, President & Director of Fulcrum Therapeutics Alexander Sapir Buys More Stock
- Mar 7th, 2024 11:35 am
Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
- Mar 5th, 2024 1:00 pm
Fulcrum Therapeutics Full Year 2023 Earnings: Beats Expectations
- Feb 28th, 2024 7:27 pm
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 2:35 pm
Q4 2023 Fulcrum Therapeutics Inc Earnings Call
- Feb 28th, 2024 2:23 am
Fulcrum Therapeutics, Inc. (FULC) Reports Q4 Loss, Tops Revenue Estimates
- Feb 27th, 2024 1:10 pm
Fulcrum Therapeutics Inc (FULC) Reports Financial Results for Q4 and Full Year 2023
- Feb 27th, 2024 12:35 pm
Fulcrum Therapeutics Announces Recent Business Highlights and Financial ResultsĀ for Fourth Quarter and Full Year 2023
- Feb 27th, 2024 12:00 pm
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8:00 a.m. ET
- Feb 20th, 2024 9:01 pm
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) institutional owners may be pleased with recent gains after 31% loss over the past year
- Feb 11th, 2024 12:06 pm
Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 1:00 pm
Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences
- Nov 9th, 2023 1:00 pm
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2023 Earnings Call Transcript
- Nov 8th, 2023 8:43 pm
Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights
- Nov 7th, 2023 1:03 pm
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023
- Nov 7th, 2023 12:00 pm
Here's Why We're Watching Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation
- Nov 3rd, 2023 12:26 pm
Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ET
- Oct 31st, 2023 12:50 pm
Scroll